Seelos Therapeutics, Inc.

VANGUARD GROUP INC

Report date

9/30/2023

Quarter

2023 Q3

Filed

12/18/2023

Shares

5,172,726

Value ($000)

952

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	12/18/2023	952	0.0%	5,172,726	9/30/2023
2023 Q2	8/14/2023	5,972	0.0%	4,997,648	6/30/2023
2023 Q1	7/14/2023	3,468	0.0%	5,016,741	3/31/2023
2022 Q4	2/10/2023	3,406	0.0%	5,016,741	12/31/2022
2022 Q3	11/14/2022	5,164	0.0%	5,014,340	9/30/2022
2022 Q2	8/12/2022	3,352	0.0%	4,927,350	6/30/2022
2022 Q1	5/13/2022	4,735	0.0%	5,650,988	3/31/2022
2021 Q4	2/14/2022	8,389	0.0%	5,146,483	12/31/2021
2021 Q3	11/12/2021	12,478	0.0%	5,177,503	9/30/2021
2021 Q2	8/13/2021	12,673	0.0%	4,800,323	6/30/2021
2021 Q1	5/14/2021	14,577	0.0%	2,921,164	3/31/2021
2020 Q4	2/12/2021	4,423	0.0%	2,799,854	12/31/2020
2020 Q3	11/16/2020	461	0.0%	491,487	9/30/2020
2020 Q2	8/14/2020	305	0.0%	301,588	6/30/2020
2020 Q1	5/15/2020	158	0.0%	321,185	3/31/2020
2019 Q4	2/14/2020	321	0.0%	239,222	12/31/2019